Analgesic Activity of the Kappa Opioid Receptor Agonist - RU-1205 in Rats / Spasov AA ... [et al.]
Introduction: Opioid analgesics are the most efficient and widely used drugs for the management of moderate to severe pain. However, side effects associated with mu receptor activation, such as respiratory depression, tolerance and physical dependence severely limit their clinical application. Curre...
Main Authors: | AA, Spasov (Author), OY, Grechko (Author), DM, Shtareva (Author), AI, Raschenko (Author), NV, Eliseeva (Author), VA, Anisimova (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Universiti Teknologi MARA Cawangan Selangor,
2018-12-31.
|
Subjects: | |
Online Access: | Get fulltext View Fulltext in UiTM IR |
Similar Items
-
Study of aversive and p38 mapk-inhibitory properties of kappa-agonist with analgesic activity – compound RU-1205
by: Alexander A. Spasov, et al.
Published: (2020-09-01) -
PHARMACOKINETIC PROPERTIES OF A NEW KAPPA-OPIOID ANALGESIC RU-1205 COMPOUND AT A SINGLE PERORAL ADMINISTRATION
by: A. A. Spasov, et al.
Published: (2021-07-01) -
Effect of adjuvant drugs on the analgesic activity of opioid morphine analgesics and compound RU-1205
by: Alexander A. Spasov, et al.
Published: (2021-09-01) -
Distribution, excretion and metabolic pathways of a single parenteral administration of kappa-opioid receptor agonist RU-1205
by: Alexander A. Spasov, et al.
Published: (2021-06-01) -
Therapeutic Potential of Kappa Opioid Agonists
by: Tyler C. Beck, et al.
Published: (2019-06-01)